Benzocaine (CAS 94-09-7) is a well-established local anesthetic and reference compound widely used in research & development laboratories, formulation testing, and analytical environments. As demand for reliable anesthetic actives grows across pharmaceutical, cosmetic, tattoo, wellness, and analytical sectors, selecting a trusted Benzocaine UK supplier becomes a critical factor for research integrity, reproducibility, and regulatory compliance.
In the United Kingdom, benzocaine powder is primarily sourced for non-clinical R&D applications, where purity, batch consistency, and documentation matter more than branding or end-consumer claims. Laboratories in England, Scotland, Northern Ireland, Ireland, as well as international partners in Germany, Netherlands, Belgium, France, Spain, Italy, Sweden, Canada, USA, Australia, New Zealand, Mexico, Estonia, Latvia, Cyprus, Hungary, Romania, Bulgaria, Slovakia, Croatia, Serbia and Albania, increasingly rely on suppliers that can guarantee safe worldwide delivery without compromising quality or traceability.
This article provides a scientific and commercial overview of benzocaine powder from the perspective of a UK-based supplier, focusing on laboratory-grade material, real R&D use cases, and global market relevance in 2026/2027.
Not all benzocaine suppliers operating in the UK meet the same technical standards. For R&D buyers, the difference between a generic distributor and a specialized laboratory supplier directly impacts experimental outcomes.
A professional Benzocaine UK supplier should provide:
✔ consistent particle morphology
✔ verified purity aligned with analytical needs
✔ clear CAS identification (94-09-7)
✔ SDS and technical documentation
✔ scalable quantities (grams → bulk)
✔ compliant logistics with safe worldwide delivery
Inconsistent benzocaine batches may lead to variable solubility, altered melting profiles, or unstable formulations, especially in dermal or semi-solid research. This is why UK laboratories often prefer suppliers that also serve EU and global R&D markets, rather than local resellers with limited chemical focus.
CristalChem, as a research-oriented supplier, positions benzocaine as a functional reagent, not a consumer product — a distinction essential for serious formulation and analytical work.
| Property | Value |
|---|---|
| Chemical name | Benzocaine |
| CAS Number | 94-09-7 |
| Molecular formula | C₉H₁₁NO₂ |
| Molecular weight | 165.19 g/mol |
| Appearance | White crystalline powder |
| Odor | Practically odorless |
| Melting point | ~88–90°C |
| Solubility | Low in water, soluble in ethanol |
For authoritative reference, benzocaine substance data aligns with entries available in PubChem – Benzocaine (CAS 94-09-7) and ChemSpider – Benzocaine compound record, which are standard verification sources for UK and EU laboratories.
A key advantage of sourcing from a specialized benzocaine UK supplier is access to controlled physical forms, which influence dispersion and handling:
| Form | R&D Advantage |
|---|---|
| Fluffy powder | High surface area, rapid dispersion |
| Mesh powder | Particle uniformity, reproducible dosing |
| Crystalline | Stability, analytical precision |
Form selection is especially relevant when benzocaine is evaluated alongside related actives such as lidocaine powder, procaine, or menthol crystals in comparative sensory or penetration studies.
In pharmaceutical R&D, benzocaine functions as:
– reference anesthetic compound
– formulation stability marker
– comparator in topical anesthetic studies
UK formulation labs frequently benchmark benzocaine against lidocaine and procaine to assess onset, solubility behavior, and crystallization tendencies under controlled conditions.
In cosmetic research environments, benzocaine is used exclusively for experimental purposes, such as:
– sensory modulation testing
– texture perception studies
– skin-contact formulation modeling
It often appears in feasibility tests alongside caffeine powder and menthol crystals to evaluate combined sensory profiles.
Tattoo-industry R&D teams across the UK, Germany, Spain, and Italy employ benzocaine powder to study:
– localized sensory response
– diffusion in gel bases
– interaction with pigments
These studies are laboratory-based and not intended for direct consumer application.
Analytical labs utilize benzocaine as:
– system suitability compound
– chromatographic reference
– identity verification standard
Guidance on documentation and handling is typically aligned with SDS best practices, such as those outlined in CristalChem’s internal SDS guide resources.
According to aggregated data from Statista, DataIntelo, and ResearchAndMarkets, the demand for anesthetic reference compounds continues to grow due to:
– expansion of topical formulation R&D
– increased cosmetic and wellness innovation
– globalization of contract research services
The UK remains a strategic R&D hub, connecting European laboratories with partners in Canada, USA, Australia, New Zealand, and Mexico. As a result, suppliers capable of safe worldwide delivery gain a measurable advantage.
Benzocaine’s stable regulatory status for research use further supports its continued relevance through 2027 and beyond.
Objective: Compare dispersion behavior of benzocaine fluffy vs mesh powder in ethanol.
Observation:
Fluffy powder disperses faster but forms transient aggregates, while mesh powder provides more reproducible concentration curves.
✔ always pre-sieve benzocaine for comparative studies
✔ store below 25°C to avoid agglomeration
✔ document batch morphology in QC logs
✔ benchmark against paracetamol powder for crystalline behavior
✔ use consistent solvent grade for reproducibility
| Compound | Solubility | Typical R&D Use |
|---|---|---|
| Benzocaine | Low water solubility | Sensory & topical models |
| Lidocaine | Higher solubility | Penetration studies |
| Procaine | Moderate | Comparative anesthetic testing |
Such comparisons are common in UK and EU laboratories performing early-stage feasibility studies.
For companies operating in the UK, benzocaine powder offers:
– low entry cost for formulation testing
– scalability from grams to bulk
– compatibility with global R&D standards
This makes benzocaine a strategic compound for pre-production experiments, private-label research, and contract laboratory services targeting European and international markets.
CristalChem supplies laboratory-grade benzocaine powder with:
✔ controlled physical forms
✔ full documentation
✔ batch traceability
✔ experience across EU & UK markets
✔ safe worldwide delivery
CristalChem’s benzocaine offering integrates seamlessly with related research compounds such as lidocaine, procaine, caffeine, and menthol, enabling structured cross-study comparisons.
ResearchAndMarkets – Topical anesthetic industry
https://www.researchandmarkets.com/reports/
PubChem – Benzocaine (CAS 94-09-7)
https://pubchem.ncbi.nlm.nih.gov/compound/Benzocaine
ChemSpider – Benzocaine compound record
https://www.chemspider.com/Chemical-Structure.2266.html
ECHA – Benzocaine CLP classification
https://echa.europa.eu/substance-information/-/substanceinfo/100.002.907
NIST WebBook – Benzocaine data
https://webbook.nist.gov/cgi/cbook.cgi?Name=benzocaine
Statista – Local anesthetics market
https://www.statista.com/outlook/hmo/pharmaceuticals/local-anesthetics/worldwide
Benzocaine supplied by CristalChem is intended exclusively for laboratory, analytical, and R&D purposes. It is not offered as a finished medicinal or consumer product. All use must comply with applicable local regulations.
Chemical Research Writer at CristalChem Academy. Passionate about chemistry, R&D, and turning laboratory insights into global wellness and industrial innovations.
